PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Department of Agriculture (USDA) has granted the company a license for CYTOPOINT™, the first monoclonal antibody ...
Cytopoint targets and neutralizes canine interleukin-31 (cIL-31), a key protein involved in triggering itch in dogs. Administered by injection once monthly, Cytopoint provides fast, long-lasting ...
Seasonal allergies affect approximately 10-15% of the dog and cat population, causing discomfort and distress to our beloved pets. 2 Spot Pet Insurance's data team examined claims involving Cytopoint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback